Literature DB >> 16937347

Tailoring cognitive-behavioral therapy for chronic pain: a case example.

Alicia A Heapy1, Michael W Stroud, Diana M Higgins, John J Sellinger.   

Abstract

Cognitive-behavioral therapy (CBT) has been shown to be an effective treatment for chronic pain. However, many patients who might benefit from this treatment either refuse treatment, fail to adhere to treatment recommendations, or drop out prematurely. Adherence to and engagement in CBT for chronic pain might be improved by tailoring a limited number of its components to individual preferences. Motivational interviewing, in which the therapist facilitates the patient's motivation for changing behavior, might also promote CBT engagement and adherence. We describe components of a tailored CBT treatment for chronic pain in the context of ongoing research and illustrate the process of tailoring CBT with a case study.

Entities:  

Mesh:

Year:  2006        PMID: 16937347     DOI: 10.1002/jclp.20314

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  4 in total

1.  Addressing both depression and pain in late life: the methodology of the ADAPT study.

Authors:  Jordan F Karp; Bruce L Rollman; Charles F Reynolds; Jennifer Q Morse; Frank Lotrich; Sati Mazumdar; Natalia Morone; Debra K Weiner
Journal:  Pain Med       Date:  2012-02-07       Impact factor: 3.750

Review 2.  [Pain in old age].

Authors:  Thomas Hubert Cegla; Johannes Horlemann
Journal:  Z Gerontol Geriatr       Date:  2018-11-19       Impact factor: 1.281

3.  Testing a path-analytic mediation model of how motivational enhancement physiotherapy improves physical functioning in pain patients.

Authors:  Gladys Cheing; Sinfia Vong; Fong Chan; Nicole Ditchman; Jessica Brooks; Chetwyn Chan
Journal:  J Occup Rehabil       Date:  2014-12

4.  Assessing a risk tailored intervention to prevent disabling low back pain--protocol of a cluster randomized controlled trial.

Authors:  Carsten Oliver Schmidt; Jean-François Chenot; Michael Pfingsten; Ruth Anja Fahland; Gabriele Lindena; Ulf Marnitz; Klaus Pfeifer; Thomas Kohlmann
Journal:  BMC Musculoskelet Disord       Date:  2010-01-05       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.